Semantic Dementia: A Mini-Review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18470%2F18%3A50013512" target="_blank" >RIV/62690094:18470/18:50013512 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00179906:_____/18:10373125

Výsledek na webu

<a href="https://www.ncbi.nlm.nih.gov/pubmed/28019640" target="_blank" >https://www.ncbi.nlm.nih.gov/pubmed/28019640</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2174/1389557516666161223155110" target="_blank" >10.2174/1389557516666161223155110</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Semantic Dementia: A Mini-Review

Popis výsledku v původním jazyce

At present there are about 47.5 million people having different types of dementia and by 2030 this number should reach 75.6 million. This obviously brings about a serious social and economic burden for people who care for those with any kind of dementia. Objective: The purpose of this article is to explore only semantic dementia (SD), more specifically called semantic variant of primary progressive aphasia, as one of the forms of frontotemporal dementia (FTD) and provide the latest information on its diagnosis and treatment which play a significant role in the maintenance of quality of life of both patients and their caregivers. Especially unimpaired communication is one of the key factors in the relationship between the patients and their caregivers. Methods: The methods used for this mini review include a literature review of available sources found in the world’s acknowledged databases such as Web of Science, PubMed, Springer and Scopus from the period of 2000 to 2015; and a comparison and evaluation of the selected studies. Results: The findings of this mini review show that FTD, respectively SD, is a serious neurodegenerative disorder which has fatal consequences for the affected patients. In addition, the findings also indicate that there are not many possibilities of pharmacological treatment for semantic dementia and therefore more attention should be paid to alternative, non-pharmacological approaches. Conclusion: Although semantic dementia is a relatively rare neurodegenerative disorder if compared with other types of dementia, it has an irreversible impact on patient’s and his/her caregiver’s life in terms of quality.

Název v anglickém jazyce

Semantic Dementia: A Mini-Review

Popis výsledku anglicky

At present there are about 47.5 million people having different types of dementia and by 2030 this number should reach 75.6 million. This obviously brings about a serious social and economic burden for people who care for those with any kind of dementia. Objective: The purpose of this article is to explore only semantic dementia (SD), more specifically called semantic variant of primary progressive aphasia, as one of the forms of frontotemporal dementia (FTD) and provide the latest information on its diagnosis and treatment which play a significant role in the maintenance of quality of life of both patients and their caregivers. Especially unimpaired communication is one of the key factors in the relationship between the patients and their caregivers. Methods: The methods used for this mini review include a literature review of available sources found in the world’s acknowledged databases such as Web of Science, PubMed, Springer and Scopus from the period of 2000 to 2015; and a comparison and evaluation of the selected studies. Results: The findings of this mini review show that FTD, respectively SD, is a serious neurodegenerative disorder which has fatal consequences for the affected patients. In addition, the findings also indicate that there are not many possibilities of pharmacological treatment for semantic dementia and therefore more attention should be paid to alternative, non-pharmacological approaches. Conclusion: Although semantic dementia is a relatively rare neurodegenerative disorder if compared with other types of dementia, it has an irreversible impact on patient’s and his/her caregiver’s life in terms of quality.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

50103 - Cognitive sciences

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Mini-reviews in medicinal chemistry

ISSN

1389-5575

e-ISSN

—

Svazek periodika

18

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

AE - Spojené arabské emiráty

Počet stran výsledku

6

Strana od-do

3-8

Kód UT WoS článku

000419734400002

EID výsledku v databázi Scopus

2-s2.0-85039802460